About
Portfolio
News
Contact
Contact us
Join Us
Contact
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
Job description
Job responsibilities
Education/Experience
Returns
Previous
2021.12.09
OncoMyx Closes $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Delivers Multiple Cancer-Killing Payloads
Next
2021.09.28
NMPA Approved Zenshine’s IND Application for ZX-7101A as influenza treatment